These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30199915)

  • 1. [The Changing Appearance of Cardiac Amyloidosis].
    Mahrholdt H; Klingel K; Sechtem U
    Dtsch Med Wochenschr; 2018 Sep; 143(18):1335-1343. PubMed ID: 30199915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Suspected cardiac amyloidosis - diagnostic steps for evaluation].
    Feldmann K; Hamm CW; Aßmus B
    Dtsch Med Wochenschr; 2020 Aug; 145(16):1162-1168. PubMed ID: 32791553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac amyloidosis: An update on diagnosis and treatment.
    Donnelly JP; Hanna M
    Cleve Clin J Med; 2017 Dec; 84(12 Suppl 3):12-26. PubMed ID: 29257735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, diagnosis, and management of cardiac amyloidosis.
    Bashir Z; Younus A; Dhillon S; Kasi A; Bukhari S
    J Investig Med; 2024 Oct; 72(7):620-632. PubMed ID: 38869161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
    Brownrigg J; Lorenzini M; Lumley M; Elliott P
    ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review.
    Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V
    Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid cardiomyopathy.
    Kristen AV
    Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue Doppler imaging and contrast-enhanced cardiac magnetic resonance in primary cardiac amyloidosis.
    Smedema JP; James R
    Eur J Echocardiogr; 2009 Dec; 10(8):984-6. PubMed ID: 19749196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
    González-López E; López-Sainz Á; Garcia-Pavia P
    Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):991-1004. PubMed ID: 28870641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of ATTR amyloidosis in endomyocardial biopsy-proven cardiac amyloidosis patients.
    Nakagawa M; Sekijima Y; Tojo K; Ikeda S
    Amyloid; 2013 Jun; 20(2):138-40. PubMed ID: 23638696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["I am a little out of breath". When a commonplace symptom hides a rare disease: cardiac amyloidosis].
    Excoffier S; Celik H; Durieux-Paillard S
    Rev Med Suisse; 2014 Sep; 10(440):1619-23. PubMed ID: 25277001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMR-based differentiation of AL and ATTR cardiac amyloidosis.
    Dungu JN; Valencia O; Pinney JH; Gibbs SD; Rowczenio D; Gilbertson JA; Lachmann HJ; Wechalekar A; Gillmore JD; Whelan CJ; Hawkins PN; Anderson LJ
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):133-42. PubMed ID: 24412186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
    Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
    Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.
    Siddiqi OK; Ruberg FL
    Trends Cardiovasc Med; 2018 Jan; 28(1):10-21. PubMed ID: 28739313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac amyloidosis diagnosed by endomyocardial biopsy. Clinical, histopathological, immunohistochemical and ultrastructural studies.
    Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Michalak E; Jakubowska E; Sobieszczańska-Małek M; Deptuch T; Walczak E; Wagner T; Walski M; Rózański J; Kiedrowski M; Lubiszewska B; Hoffman P; Rózyłło W
    Kardiol Pol; 2005 Jul; 63(7):20-35. PubMed ID: 16136426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What should we know about cardiac amyloidosis? From clinical signs to treatment].
    Földeák D; Nemes A; Kalapos A; Domsik P; Kormányos Á; Krenács L; Bagdi E; Borbényi Z
    Orv Hetil; 2017 Nov; 158(46):1811-1818. PubMed ID: 29135289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging in cardiac amyloidosis.
    Pennell DJ; Maceira AM
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1378-80. PubMed ID: 20083071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.